drugset / Trial / NCT02867176
Pain Management in Corneal Collagen Crosslinking for Keratoconus
RandomizedParallel-groupSingle-blindSupportive care
Summary
This is a prospective, randomized, single blind study. Patients enrolled in the study were randomly assigned to a ketorolac or a gabapentin group for pain control. Different pain scores and variables will be evaluated, along with others side effects variables.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | 300 mg | — |
| Subject | Ketorolac | Other / unclassified | 10 mg | — |
Indications
No indication recorded.